drug protocol number

80202135EBF3001

drug sponsor

Janssen Research & Development

drug study

Nipocalimab

drug trial site

King Faisal Specialist Hospital and Research Center (Riyadh), King Saud Medical City (Riyadh), King Fahad University Hospital (Al-Khobar)

drug status

Ongoing

drug phase